Ari Nowacek

Ari Nowacek, M.D, Ph.D., is a Principal with ARCH Venture Partners. Dr. Nowacek focuses on identifying/evaluating new life science technologies, forming new companies, and provides operational assistance to early-stage portfolio companies. Dr. Nowacek is a physician-scientist by training with publications in the areas of neuroscience, virology, and antiretroviral therapeutic development. His research has led to 3 issued and 2 pending patents for therapeutic and R&D applications.

Ari holds a B.S. in Biology and a B.S. in Psychology from the University of Indiana-Bloomington where he graduated Magna Cum Laude and was elected to Phi Beta Kappa. He also holds an M.D. and Ph.D. from the University of Nebraska Medical Center and an M.B.A. from the University of Nebraska-Omaha. He subsequently completed a medical residency in pathology and post-doctoral research at The University of Chicago, Harvard Medical Schools and Massachusetts General Hospital.